	Ebitda		日
AbbVie	USD 5.37B	1.85B	2025-12
Amgen	USD 5.14B	775M	2025-12
Anika Therapeutics	USD 4.54M	3.67M	2025-12
Arrowhead Research	USD 57.17M	7.03M	2025-12
AstraZeneca	USD 5.67B	1.29B	2026-03
BioCryst Pharmaceuticals	USD 51.7M	30.14M	2025-09
Biogen	USD 649.7M	76.5M	2026-03
Bristol-Myers Squibb	USD 2.88B	1.36B	2025-12
Gilead Sciences	USD 3.02B	1.01B	2025-12
GlaxoSmithKline	GBP 2.77B	1.65B	2026-03
Halozyme Therapeutics	USD 219.57M	197.66M	2026-03
Heron Therapeutics	USD -3.88M	5.63M	2024-09
Immunic	USD -22.78M	753K	2024-06
Incyte	USD 367.97M	46.53M	2026-03
Insmed	USD -148.3M	165.88M	2026-03
Ionis Pharmaceuticals	USD -200.02M	42.89M	2025-12
J&J	USD 7.19B	2.32B	2025-12
Karyopharm Therapeutics	USD -26.2M	1.83M	2024-09
Ligand Pharmaceuticals	USD 66.78M	83.54M	2025-12
Merck	USD 6.3B	2.09B	2025-12
Neurocrine Biosciences	USD 193.3M	25.1M	2026-03
Novartis	USD 5.3B	530M	2026-03
Novavax	USD 19.36M	190.79M	2025-12
Pfizer	USD 5.99B	5.23B	2026-03
PTC Therapeutics	USD -70.99M	91.62M	2025-12
Roche Holding	CHF 12.68B	2.36B	2024-06
Sarepta Therapeutics	USD -252.2M	84.16M	2025-12
Vertex Pharmaceuticals	USD 1.19B	195.3M	2026-03